Cargando…
miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma
The development of multidrug-resistance (MDR) is a major contributor to death in colorectal carcinoma (CRC). Here, we investigated the possible role of microRNA (miR)-503-5p in drug resistant CRC cells. Unbiased microRNA array screening revealed that miR-503-5p is up-regulated in two oxaliplatin (OX...
Autores principales: | Xu, Ke, Chen, Guo, Qiu, Yanyan, Yuan, Zeting, Li, Hongchang, Yuan, Xia, Sun, Jian, Xu, Jianhua, Liang, Xin, Yin, Peihao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400618/ https://www.ncbi.nlm.nih.gov/pubmed/28423513 http://dx.doi.org/10.18632/oncotarget.15559 |
Ejemplares similares
-
circNRIP1 facilitates keloid progression via FXR1-mediated upregulation of miR-503-3p and miR-503-5p
por: Wang, Baolin, et al.
Publicado: (2021) -
LncRNA MIR503HG Promotes High-Glucose-Induced Proximal Tubular Cell Apoptosis by Targeting miR-503-5p/Bcl-2 Pathway
por: Cao, Xu, et al.
Publicado: (2020) -
Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis
por: Huang, Ming-Zhi, et al.
Publicado: (2020) -
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
por: Zhang, Chun-Zhi, et al.
Publicado: (2010) -
The Causes and Consequences of miR-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer
por: He, Yanjing, et al.
Publicado: (2021)